Talimogene laherparepvec causes lysis of tumors, followed by release of tumor- derived antigens, which together with virally derived granulocyte macrophage-colony stimulating factor (GM-CSF) may promote an antitumor immune response (9). Here, CSF2 is linked to neoplasm.